High materiality8/10
Genmab A/S (GMAB) PT Raised to $54 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim upgrades GMAB target to $54 from $34.75; current posted price $34.75. The new target implies meaningful upside and the price has moved about +10.73 since the signal, suggesting momentum.
- Target raised to $54; current price $34.75; price change +10.73 since signal.
Key facts
- 01
Target: $54
- 02
Posted price: $34.75
- 03
Analyst firm: Guggenheim
- 04
Analyst: Michael Schmidt
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.